COPDGene Ancillary Proposal: Symbicort Intervention in "Airway Predominant
Phase of Trial: Phase IV
Latest Information Update: 31 Mar 2017
At a glance
- Drugs Budesonide (Primary) ; Budesonide/formoterol (Primary) ; Salbutamol/ipratropium bromide
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms SACOPD
- 27 Mar 2017 Status changed from active, no longer recruiting to completed.
- 05 Oct 2015 Planned End Date changed from 1 Jul 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov record.
- 05 Oct 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.